An open-label trial of olanzapine for corticosteroid-induced mood symptoms

被引：1
|
作者：
Brown, ES
Chamberlain, W
Dhanani, N
Paranjpe, P
Sargeant, M
机构：
来源：
PSYCHOSOMATICS | 2004年 / 45卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：147 / 148
页数：2
相关论文
共 50 条
  • [31] Evaluation of the Effectiveness and Safety of Olanzapine as an Adjunctive Treatment for Anorexia Nervosa in Adolescents: An Open-Label Trial
    Spettigue, Wendy
    Norris, Mark L.
    Maras, Danijela
    Obeid, Nicole
    Feder, Stephen
    Harrison, Megan E.
    Gomez, Rebecca
    Fu, Maeghan C. Y.
    Henderson, Katherine
    Buchholz, Annick
    JOURNAL OF THE CANADIAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2018, 27 (03) : 197 - 208
  • [32] Recurrent cases of corticosteroid-induced mood disorder - clinical characteristics and treatment
    Wada, K
    Yamada, N
    Suzuki, H
    Lee, Y
    Kuroda, S
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2002, 17 : S43 - S43
  • [33] Lithium therapy for corticosteroid-induced mood disorder - Wada and colleagues reply
    Wada, K
    Yamada, N
    Suzuki, H
    Lee, Y
    Kuroda, S
    JOURNAL OF CLINICAL PSYCHIATRY, 2001, 62 (01) : 57 - 58
  • [34] Open-Label Treatment With Olanzapine for Patients With Borderline Personality Disorder
    Zanarini, Mary C.
    Schulz, S. Charles
    Detke, Holland
    Zhao, Fangyi
    Lin, Daniel
    Pritchard, Mary
    Deberdt, Walter
    Fitzmaurice, Garrett
    Corya, Sara
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2012, 32 (03) : 398 - 402
  • [35] Effective open-label treatment of Tourette's disorder with olanzapine
    Stamenkovic, M
    Schindler, SD
    Aschauer, HN
    de Zwaan, M
    Willinger, U
    Resinger, E
    Kasper, S
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2000, 15 (01) : 23 - 28
  • [36] Open-label olanzapine monotherapy in treatment refractory bipolar mania
    Colangelo, E. M.
    Muzina, D. J.
    Negrelli, J.
    Conroy, C.
    Calabrese, J. R.
    BIPOLAR DISORDERS, 2007, 9 : 29 - 29
  • [37] Open-label treatment with olanzapine in patients with borderline personality disorder
    Zanarini, M. C.
    Schulz, S. C.
    Detke, H. C.
    Zhao, F.
    Lin, D.
    Deberdt, W.
    Corya, S.
    EUROPEAN PSYCHIATRY, 2008, 23 : S93 - S93
  • [38] Open-Label Treatment with Olanzapine for Patients with Borderline Personality Disorder
    Schulz, S. Charles
    Zanarini, Mary C.
    JOURNAL OF PERSONALITY DISORDERS, 2011, 25 : 34 - 35
  • [39] Open-label study of olanzapine in children with pervasive developmental disorder
    Kemner, C
    Willemsen-Swinkels, SHN
    de Jonge, M
    Tuynman-Qua, H
    van Engeland, H
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2002, 22 (05) : 455 - 460
  • [40] Effects of duloxetine on motor and mood symptoms in Parkinson's disease: An open-label clinical experience
    Nishijima, Haruo
    Ueno, Tatsuya
    Kon, Tomoya
    Haga, Rie
    Funamizu, Yukihisa
    Arai, Akira
    Suzuki, Chieko
    Nunomura, Jin-ichi
    Baba, Masayuki
    Tomiyama, Masahiko
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 375 : 186 - 189
12345